Randomized Controlled 8-week Crossover Evaluation of Compression Bandage Systems for Venous Leg Ulcers
NCT ID: NCT00301496
Last Updated: 2024-10-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2006-03-31
2007-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Randomized Clinical Trial (RCT) to Compare the Efficacy of Coban 2 Versus SSB in the Treatment of Venous Leg Ulcers
NCT00558662
A Clinical Study to Assess a Compression Device in Patients With Venous Leg Ulcers
NCT02561013
Cost Evaluation of Venous Leg Ulcers Management
NCT02728986
Effectiveness of Double-layer Compression Therapy in the Healing of Chronic Venous Ulcers in Primary Health Care
NCT02364921
A Study to Evaluate the Clinical Effectiveness of a Collagen-ORC Antimicrobial Matrix in Venous Leg Ulcers
NCT00235209
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Coban 2 Layer Compression System
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient can walk
Exclusion Criteria
* diabetic foot ulcer
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
3M
INDUSTRY
Solventum US LLC
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christine Moffatt, PhD, MA, RGN
Role: PRINCIPAL_INVESTIGATOR
Centre for Research and Implementation of Clinical Practice
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute for Advanced Wound Care
Montgomery, Alabama, United States
Center for Clinical Research, Inc.
Castro Valley, California, United States
Gwinnet Hospital System
Lawrenceville, Georgia, United States
Wound Healing and Treatment Center - Silver Cross Hospital
Joliet, Illinois, United States
Wound Healing Center
Terre Haute, Indiana, United States
Dermatology Clinic - Montreal General Hospital
Montreal, Quebec, Canada
Dermatology Clinic
Mississauga, Ontario, , Canada
Wound Healing Research Unit
Cardiff, , United Kingdom
Grantham & District Hospital
Grantham, , United Kingdom
Clayponds Hospital
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
05-010302
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.